Major depressive disorder is the most common of all psychiatric disorders, and has a profound impact on individual and family quality of life and activities of daily living. While depression can be effectively treated in the majority of patients by medication and psychotherapy, up to 30% of patients fail to respond to any treatment.

The Renova-DT™ Cortical Stimulation System* delivers targeted stimulation to the prefrontal cortex in patients with major depressive disorder. The PROSPECT feasibility study is presently underway to determine the feasibility of treating major depressive disorder with cortical stimulation.

*Caution: Investigational device. Limited by Federal (or U.S.) law to investigational use.